|
1
|
Lloyd RV, Osamura RY, Klöppel G and Rosai
J (eds): WHO Classification of Tumours of Endocrine Organs. Vol 10.
4th edition. IARC Press, Lyon, 2017.
|
|
2
|
Rizen EN and Phan AT: Neuroendocrine
tumors: A relevant clinical update. Curr Oncol Rep. 24:703–714.
2022.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jensen RT, Bodei L, Capdevila J, Couvelard
A, Falconi M, Glasberg S, Kloppel G, Lamberts S, Peeters M, Rindi
G, et al: Unmet needs in functional and nonfunctional pancreatic
neuroendocrine neoplasms. Neuroendocrinology. 108:26–36.
2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yang M, Tian B, Zhang Y, Su A, Yue P, Xu S
and Wang L: Epidemiology, diagnosis, surgical treatment and
prognosis of the pancreatic neuroendocrine tumors: Report of 125
patients from one single center. Indian J Cancer. 52:343–349.
2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Das S and Dasari A: Epidemiology,
incidence, and prevalence of neuroendocrine neoplasms: Are there
global differences? Curr Oncol Rep. 23(43)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Öberg K: Management of functional
neuroendocrine tumors of the pancreas. Gland Surg. 7:20–27.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kasajima A and Klöppel G: Neuroendocrine
neoplasms of lung, pancreas and gut: A morphology-based comparison.
Endocr Relat Cancer. 27:R417–R432. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gill A, Klimstra D and Lam A (eds): WHO
Classification of Tumours: Digestive System Tumours. 5th edition.
International Agency for Research on Cancer, Lyon, 20190.
|
|
9
|
Konukiewitz B, Jesinghaus M, Kasajima A
and Klöppel G: Neuroendocrine neoplasms of the pancreas: Diagnosis
and pitfalls. Virchows Arch. 480:247–257. 2022.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Reid MD, Bagci P, Ohike N, Saka B, Erbarut
Seven I, Dursun N, Balci S, Gucer H, Jang KT, Tajiri T, et al:
Calculation of the Ki67 index in pancreatic neuroendocrine tumors:
A comparative analysis of four counting methodologies. Mod Pathol.
28:686–694. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Crona J, Norlen O, Antonodimitrakis P,
Welin S, Stalberg P and Eriksson B: Multiple and secondary hormone
secretion in patients with metastatic pancreatic neuroendocrine
tumours. J Clin Endocri nol Metab. 101:445–452. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hofland J, Falconi M, Christ E, Castaño
JP, Faggiano A, Lamarca A, Perren A, Petrucci S, Prasad V,
Ruszniewski P, et al: European Neuroendocrine Tumor Society 2023
guidance paper for functioning pancreatic neuroendocrine tumour
syndromes. J Neuroendocrinol. 35(e13318)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zilli A, Arcidiacono PG, Conte D and
Massironi S: Clinical impact of endoscopic ultrasonography on the
management of neuroendocrine tumors: Lights and shadows. Dig Liver
Dis. 50:6–14. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Alshareefy Y, Cummins S, Mazzoleni A,
Sharma V, Guggilapu S, Leong AWY and Wireko AA: A review of
functional pancreatic neuroendocrine tumors: Exploring the
molecular pathogenesis, diagnosis and treatment. Medicine
(Baltimore). 102(e36094)2023.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Ito T, Masui T, Komoto I, Doi R, Osamura
RY, Sakurai A, Ikeda M, Takano K, Igarashi H, Shimatsu A, et al:
JNETS clinical practice guidelines for gastroenteropancreatic
neuroendocrine neoplasms: Diagnosis, treatment, and follow-up: A
synopsis. J Gastroenterol. 56:1033–1044. 2021.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Titan AL, Norton JA, Fisher AT, Foster DS,
Harris EJ, Worhunsky DJ, Worth PJ, Dua MM, Visser BC, Poultsides
GA, et al: Evaluation of outcomes following surgery for locally
advanced pancreatic neuroendocrine tumors. JAMA Netw Open.
3(e2024318)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rinke A, Ambrosini V, Dromain C,
Garcia-Carbonero R, Haji A, Koumarianou A, van Dijkum EN, O'Toole
D, Rindi G, Scoazec JY and Ramage J: European Neuroendocrine Tumor
Society (ENETS) 2023 guidance paper for colorectal neuroendocrine
tumours. J Neuroendocrinol. 35(e13309)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wu Z, Wang W, Zhang K, Fan M and Lin R:
The impact of surgery and survival prediction in patients with
gastroenteropancreatic neuroendocrine tumors: A population-based
cohort study. Int J Surg. 109:1629–1638. 2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Loosen SH, Kostev K, Eschrich J, Krieg S,
Krieg A, Luedde T, Jann H and Roderburg C: Clinical characteristics
of 662 patients with pancreatic neuroendocrine tumors receiving
antitumoral therapy. Medicine (Baltimore).
101(e32044)2022.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rikhraj N, Fernandez CJ, Ganakumar V and
Pappachan JM: Pancreatic neuroendocrine tumors: A case-based
evidence review. World J Gastrointest Pathophysiol.
16(107265)2025.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Popa SG, Golli AL, Matei CF, Sonei AN,
Vere C, Cimpeanu R, Munteanu M and Munteanu A: Pancreatic
neuroendocrine tumors-diagnostic pitfalls of non-diabetic severe
hypoglycemia: Literature review and case report. Diagnostics
(Basel). 15(337)2025.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Danek E, Kavnoudias H, McLean C,
Gerstenmaier JF and Di Muzio B: Radiological variability in
pancreatic neuroendocrine neoplasms: A 10-year single-center study
on atypical presentations and diagnostic challenges. Biomedicines.
13(496)2025.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Yalcin S and Öberg K (eds): Neuroendocrine
Tumours: Diagnosis and Management. 2nd edition. Springer
International Publishing, Cham, 2024.
|
|
24
|
Klöppel G: Neuroendocrine neoplasms:
Dichotomy, origin and classifications. Visc Med. 33:324–330.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hu C, Chen Y, Yin X, Xu R, Yin C, Wang C
and Zhao Y: Pancreatic endocrine and exocrine signaling and
crosstalk in physiological and pathological status. Signal
Transduct Target Ther. 10(39)2025.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhu X, Xiao Z, Liu H, Zhang P, Deng S,
Ding L, Feng J, Luo J, Ni Q, Luo G and Yu X: Pancreatic Cancer: An
Exocrine Tumor With Endocrine Characteristics. Ann Surg.
280:e17–e25. 2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Fang JM, Li J and Shi J: An update on the
diagnosis of gastroenteropancreatic neuroendocrine neoplasms. World
J Gastroenterol. 28:1009–1023. 2022.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Sonbol MB and Halfdanarson TR: Management
of well-differentiated high-grade (G3) neuroendocrine tumors. Curr
Treat Options Oncol. 20(74)2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ma ZY, Gong YF, Zhuang HK, Zhou ZX, Huang
SZ, Zou YP, Huang BW, Sun ZH, Zhang CZ, Tang YQ and Hou BH:
Pancreatic neuroendocrine tumors: A review of serum biomarkers,
staging, and management. World J Gastroenterol. 26:2305–2322.
2020.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Oronsky B, Ma PC, Morgensztern D and
Carter CA: Nothing but NET: A review of neuroendocrine tumors and
carcinomas. Neoplasia. 19:991–1002. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Fairweather M, Swanson R, Wang J, Brais
LK, Dutton T, Kulke MH and Clancy TE: Management of neuroendocrine
tumor liver metastases: Long-term outcomes and prognostic factors
from a large prospective database. Ann Surg Oncol. 24:2319–2325.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Falconi M, Eriksson B, Kaltsas G, Bartsch
DK, Capdevila J, Caplin M, Kos-Kudla B, Kwekkeboom D, Rindi G,
Klöppel G, et al: ENETS consensus guidelines update for the
management of patients with functional pancreatic neuroendocrine
tumors and non-functional pancreatic neuroendocrine tumors.
Neuroendocrinology. 103:153–171. 2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ahmed M: Gastrointestinal neuroendocrine
tumors in 2020. World J Gastrointest Oncol. 12:791–807.
2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ambrosini V, Kunikowska J, Baudin E, Bodei
L, Bouvier C, Capdevila J, Cremonesi M, de Herder WW, Dromain C,
Falconi M, et al: Consensus on molecular imaging and theranostics
in neuroendocrine neoplasms. Eur J Cancer. 146:56–73.
2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mpilla GB, Philip PA, El-Rayes B and Azmi
AS: Pancreatic neuroendocrine tumors: Therapeutic challenges and
research limitations. World J Gastroenterol. 26:4036–4054.
2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Pulvirenti A, Javed AA, Michelakos T,
Sekigami Y, Zheng J, Kalvin HL, McIntyre CA, Nebbia M, Chou JF,
Gonen M, et al: Recurring pancreatic neuroendocrine tumor: Timing
and pattern of recurrence and current treatment. Ann Surg.
278:e1063–e1067. 2023.PubMed/NCBI View Article : Google Scholar
|
